TORCs
Michael D. Conkright(Scripps Research Institute), Marc Montminy(Salk Institute for Biological Studies), John B. Hogenesch(Translational Therapeutics (United States)), Loren Miraglia(Genomics Institute of the Novartis Research Foundation), Robert A. Screaton(Salk Institute for Biological Studies), Gianluca Canettieri(Istituto Pasteur), Ernesto Guzmán(Salk Institute for Biological Studies)
Cited by 609